Skip to main content

3 Result(s)

within Mayeule Legrand Remove this filter

and

  1. No Access

    Article

    Population pharmacokinetic analysisof lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART

    This work aimed at building a population pharmacokinetic (PK) model for lamivudine (LMV), stavudine (STV) and zidovudine (ZDV), estimating their inter and intraindividual PK variability and investigating the i...

    Xavière Panhard, Mayeule Legrand… in European Journal of Clinical Pharmacology (2007)

  2. No Access

    Article

    High Variability of Indinavir and Nelfinavir Pharmacokinetics in HIV-infected Patients with a Sustained Virological Response on Highly Active Antiretroviral Therapy

    To describe plasma concentrations of indinavir alone or combined with ritonavir, and of nelfinavir and its active metabolite M8, and to measure their variabilities in HIV-infected patients treated with a stabl...

    Dr Cécile Goujard, Mayeule Legrand, Xavière Panhard… in Clinical Pharmacokinetics (2005)

  3. No Access

    Article

    Pharmacodynamics and pharmacokinetics of single nasal (5 mg and 10 mg) and oral (50 mg) doses of ephedrine in healthy subjects

    Objective: To determine the cardiovascular, subjective effects and potential of abuse liability of single dose (–) ephedrine (E) administered orally (50 mg) or intranasally (10 mg and 5 mg). Methods: Sixteen hea...

    Ivan Berlin, Dominique Warot, Guy Aymard… in European Journal of Clinical Pharmacology (2001)